NEW
YORK, July 17, 2024 /PRNewswire/ -- LANGaware, a
pioneering AI-driven healthcare technology company, has been
awarded a national group purchasing agreement for Patient
Engagement Solutions with Premier, Inc. Effective July 1st, 2024, the new agreement allows Premier
members, at their discretion, access to LANGaware's advanced
screening technology at special pricing and terms pre-negotiated by
Premier.
LANGaware utilizes AI to predict and monitor neurodegenerative
and behavioral health conditions such as Mild Cognitive Impairment
(MCI), Alzheimer's Disease (AD), and Depression. By analyzing
digital biomarkers based on language, voice, and speech,
LANGaware's platform offers unmatched accuracy in early detection,
leading to improved patient outcomes, enhanced quality of life, and
reduced healthcare costs. The integration of LANGaware's technology
can help providers reduce costs through enhanced early diagnosis
and timely interventions, while also driving revenue by offering a
new billable service and improving patient satisfaction with
accurate and efficient assessments.
Developed through years of rigorous research and testing,
LANGaware's patented technology is transforming early cognitive and
behavioral health disease detection. By minimizing the risk of
misdiagnosis and unnecessary treatments, LANGaware provides
healthcare providers with a powerful tool for early detection,
personalized support, and treatment monitoring.
"We are thrilled to join Premier's network and extend our
digital assessment tool's reach to more patients, hospitals, and
providers," said Vassiliki Rentoumi, Founder and CEO of LANGaware.
"Our goal is to revolutionize early diagnosis, improve patient
outcomes, and drive positive changes in the healthcare
industry."
This collaboration marks a significant step forward in expanding
access to advanced diagnostic services across the United States. Combining Premier's
extensive member network with LANGaware's cutting-edge technology
aims to revolutionize healthcare through innovative solutions.
Premier is a leading healthcare improvement company, uniting an
alliance of approximately 4,350 U.S. hospitals and 300,000 other
providers to transform healthcare. With integrated data and
analytics, collaboratives, supply chain solutions, consulting and
other services, Premier enables better care and outcomes at a lower
cost.
LANGaware leverages AI technology to revolutionize cognitive and
behavioral health screening. By utilizing speech analysis and
proprietary voice and speech biomarkers, LANGaware provides early,
accurate and objective detection of conditions, enabling more
effective treatments, reducing healthcare burdens, and improving
overall well-being. For more information about LANGaware, please
visit www.langaware.com.
Media Contacts:
Virginia
Korma
646-878-9063
virginia@langaware.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/langaware-awarded-patient-engagement-solutions-agreement-with-premier-inc-for-early-detection-of-cognitive-and-behavioral-health-diseases-302196557.html
SOURCE LANGaware